1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. INTENSITY THERAPEUTICS INC
Intensity Therapeutics Inc
XNAS: INTS
Download real time
5.21 0.01 (0.19%)
88.02% Fall from 52W High
40,183
XNAS Volume

XNAS 05 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Intensity Therapeutics Inc is on 13 May 2026 for the purpose of Intensity Therapeutics Inc First Quarter Earnings Results for 2026 See details


Insider Trading disclosures for Intensity Therapeutics Inc

The latest disclosure was made by Lewis H. Bender in Intensity Therapeutics Inc where a trade of 37,749 Common Stock, $0.0001 Par Value done at an average price of $6.1 was reported to US exchanges on March 26, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Lewis H. Bender Director, President and CEO Grant, award, or other acquisition of securities at price $ 6.11 per share. 26 Mar 2026 37,749 118,549 - 6.1 230,646 Common Stock, $0.0001 Par Value
John Wesolowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.26 per share. 31 Dec 2025 8,918 85,354 - 0.3 2,337 Common Stock, $0.0001 Par Value
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.26 per share. 31 Dec 2025 14,482 28,661 - 0.3 3,794 Common Stock, $0.0001 Par Value
John Wesolowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.26 per share. 30 Jun 2025 69,745 76,436 - 0.3 18,203 Common Stock, $0.0001 Par Value
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.26 per share. 30 Jun 2025 14,179 14,179 - 0.3 3,701 Common Stock, $0.0001 Par Value
Lewis H. Bender Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2025 700,000 700,000 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2025 100,000 100,000 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2025 100,000 100,000 - - Stock Option (right to buy Common Stock)
Emer Leahy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2025 50,000 50,000 - - Stock Option (right to buy Common Stock)
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2025 300,000 300,000 - - Stock Option (right to buy Common Stock)
Thomas I.H. Dubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 May 2025 50,000 50,000 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 70,028 70,028 - - Stock Option (right to buy Common Stock)
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Oct 2024 427,379 427,379 - - Stock Option (right to buy Common Stock)
John Wesolowski Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. 05 Jun 2024 1,000 6,691 - 4 4,000 Common Stock, $0.0001 Par Value
John Wesolowski Principal Accounting Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Jun 2024 1,000 14,000 - - Stock Option (right to buy Common Stock)
Thomas I.H. Dubin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 May 2024 50,000 50,000 - - Stock Option (right to buy Common Stock)
John Wesolowski See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 25,000 25,000 - - Stock Option (right to buy Common Stock)
Emer Leahy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 50,000 50,000 - - Stock Option (right to buy Common Stock)
Lewis H. Bender Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 33,574 33,574 - - Stock Option (right to buy Common Stock)
Lewis H. Bender Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2024 464,805 464,805 - - Stock Option (right to buy Common Stock)
Joseph Talamo Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Dec 2023 80,000 80,000 - - Stock Option (right to buy Common Stock)
John Wesolowski Interim CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jul 2023 50,000 50,000 - - Stock Option (right to buy Common Stock)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters